PROTAB SATIVA / 5 tablets · 0.01g
$27after tax
weeddispensarynearme.com
You must be 21 years or older to enter. By entering, you confirm you’re of legal age in your state to purchase cannabis.
For use only by adults 21+ • Keep out of reach of children
Brand · 12 products live
LEVEL is a science-driven cannabis company that operates on the cutting edge, pioneering a fresh approach and a paradigm shift in how humans interact with the plant. Our goal is to provide a way to seamlessly incorporate cannabis into your everyday life. Led by visionary CEO and chief scientist, Chris Emerson, PhD, the LEVEL story is one of innovation, passion, and a relentless pursuit of excellence. Join us on this journey as we continue to revolutionize the way people think about the cannabis. LEVEL is more than a just a cannabis company, it's a way of life and a celebration of the incredible potential of plant medicine. We invite you to experience the possibilities.
Quick answer · What is the LEVEL cannabis brand?
LEVEL is a science-forward cannabis company founded in California and led by CEO and chief scientist Chris Emerson, PhD. Known for its precision-dosed, research-informed approach to edibles and cannabinoid formulation, LEVEL occupies a distinctive position in the market — one oriented toward educated consumers who treat cannabis as a wellness tool rather than a recreational novelty. In New York dispensaries, LEVEL is available in the edibles category.
LEVEL is a science-forward cannabis company founded in California and led by CEO and chief scientist Chris Emerson, PhD. Known for its precision-dosed, research-informed approach to edibles and cannabinoid formulation, LEVEL occupies a distinctive position in the market — one oriented toward educated consumers who treat cannabis as a wellness tool rather than a recreational novelty. In New York dispensaries, LEVEL is available in the edibles category.
LEVEL was founded in California with a mandate that distinguished it from the majority of cannabis brands entering the post-legalization market: rather than leading with flower aesthetics or lifestyle imagery, the company centered its identity on cannabinoid science. Chris Emerson, who holds a doctorate and has been publicly identified as both CEO and chief scientist, built the brand around the idea that cannabis consumers deserve the same rigor in product formulation that they might expect from a nutraceutical or pharmaceutical company. The exact founding year has not been consistently disclosed across all public sources, though LEVEL has been operating in the California licensed market for several years and was an early participant in that state's adult-use framework after 2018. The core gap LEVEL identified was the imprecision of most cannabis products — inconsistent dosing, poorly understood cannabinoid ratios, and a lack of education around minor cannabinoids such as CBN, THCV, and CBC. LEVEL responded by developing tightly dosed formats, particularly its Tablinguals (fast-dissolve tablets), which became a signature product category in California. The brand's entry into New York's adult-use market, where it is currently available in the edibles category at select licensed dispensaries including ZenZest, represents a natural extension of its mission to reach consumers seeking a more considered, deliberate relationship with cannabinoids.
LEVEL's visual identity is deliberately clinical and restrained, drawing more from pharmaceutical and scientific design vocabularies than from the streetwear-inflected or farm-to-table aesthetics that dominate much of the cannabis market. Packaging tends toward clean white and neutral tones, with clear typographic hierarchy that prioritizes cannabinoid information, dosage, and effect descriptors over decorative elements. The overall impression is of a brand that trusts its consumer to read and evaluate rather than one that needs to seduce through color or imagery. The shopper persona LEVEL courts is analytically minded — someone who researches before they purchase, who is as likely to read a white paper on the endocannabinoid system as a strain review, and who views cannabis integration into daily life as a matter of calibration rather than indulgence. In market terms, LEVEL occupies the craft-to-luxury tier not through opulence but through intellectual positioning: the premium is charged for formulation precision and cannabinoid transparency rather than for ornate packaging. This places the brand alongside science-forward peers in a rarefied niche that is still underserved in most legal markets.
LEVEL's product philosophy centers on extraction and formulation rather than cultivation, with the brand's competitive advantage residing in how it processes and combines cannabinoids rather than in proprietary growing methods. The company has been publicly associated with approaches that isolate and recombine specific cannabinoids — including minor cannabinoids that most brands ignore — to produce precise, targeted effects. This is a more pharmaceutical approach to cannabis manufacturing, and it differentiates LEVEL sharply from brands whose identity is rooted in whole-flower expression. For its edibles, LEVEL has historically emphasized bioavailability and onset consistency, areas where the edibles category has long struggled to deliver reliable consumer experiences. The Tablingual format, a fast-dissolving sublingual tablet, is designed to bypass some of the variability associated with traditional oral ingestion through the digestive tract, allowing for more predictable onset windows. While specific extraction methodologies used in New York production or distribution have not been independently detailed in public filings at the time of writing, the brand's California-origin formulation philosophy — favoring precision over volume and clarity over complexity — is understood to inform all market entries. Consumers should consult current product labeling and dispensary staff for state-specific production details.
LEVEL's most recognized product format is the Tablingual, a small, fast-dissolving tablet designed for sublingual or buccal absorption. This format became something of a category-defining innovation in California, offering cannabis consumers a discreet, precisely dosed delivery method with a more predictable onset than a conventional gummy or chocolate. The Tablinguals are available in multiple cannabinoid formulations — including options that incorporate minor cannabinoids like CBN for rest-oriented use cases or THCV for more energetic applications — giving the line meaningful range for different occasions and consumer needs. Beyond Tablinguals, LEVEL has developed additional edibles formats consistent with its emphasis on dose control and functional design. Across all formats, the through-line is the same: a relatively modest dose per unit, a clear statement of intended effect, and a formulation that reflects the brand's commitment to minor cannabinoid research. In New York's edibles category specifically, LEVEL's offerings present an alternative to the confection-forward products that dominate shelf space, appealing to consumers who prioritize function and precision over flavor experience.
LEVEL occupies a specific and somewhat unusual occasion space compared to most edibles brands. Rather than positioning primarily around social consumption, celebration, or flavor enjoyment, the brand appeals most naturally to consumers who are incorporating cannabis into structured daily routines — a wind-down protocol before sleep, a focus-support ritual before creative work, or a deliberate micro-dose during a busy afternoon. The Tablingual format in particular suits these use cases: it is discreet, fast to administer, and consistent enough in its effects to build a habit around. Gifting is another occasion where LEVEL performs well, particularly for the consumer who wants to give something that reads as thoughtful and sophisticated rather than recreational. The clean packaging and scientific positioning make it an appropriate choice for a wellness-oriented friend or a cannabis-curious professional who might be skeptical of more overtly recreational branding. Weekend craft sessions or festival consumption are less central to LEVEL's brand world — this is a brand for the measured, intentional consumer rather than for high-volume social occasions.
LEVEL was founded and licensed in California, where it built its reputation and developed its signature product formats within that state's adult-use regulatory framework. The brand is not publicly listed as a New York OCM-licensed grower or processor at the time of writing; its presence in New York's adult-use market is understood to operate through the state's licensed wholesale and distribution channels, consistent with how out-of-state brands enter the NY market via compliant M-to-A (manufacturer-to-adult-use retailer) pathways. Consumers seeking current licensing confirmation should consult the New York Office of Cannabis Management's public registry. LEVEL has not publicly disclosed social-equity, women-owned, or BIPOC-owned certification status in sources reviewed for this profile. The brand's primary market remains California, with New York representing one of its earlier East Coast distribution entries. Further multi-state expansion details, if any, have not been widely reported in trade press at the time of writing.
$27after tax
$11after tax

$11after tax
$6after tax
$27after tax
$27after tax
$27after tax
$27after tax
$6after tax
$27after tax
$6after tax

$11after tax
LEVEL was founded and developed its manufacturing operations in California, where it holds licensure under that state's adult-use framework. For New York consumers, products available at licensed dispensaries like ZenZest enter the market through compliant New York wholesale and distribution channels. Specific production facility details for New York-distributed inventory have not been publicly detailed; dispensary staff can provide current sourcing information.
Based on publicly available information at the time of writing, LEVEL is not listed as a New York OCM-licensed grower or processor. The brand's products are understood to reach New York's adult-use market through the state's licensed wholesale distribution network. For the most current licensing status, consumers are encouraged to consult the New York Office of Cannabis Management's public license registry.
LEVEL is best known for its science-driven approach to cannabis formulation, particularly its Tablingual product — a fast-dissolving sublingual tablet that delivers precise cannabinoid doses with a more predictable onset than conventional edibles. The brand is also recognized for its work with minor cannabinoids such as CBN and THCV, distinguishing it from brands that rely exclusively on THC and CBD.
For a first experience with LEVEL, the Tablingual format is the most representative of the brand's philosophy — precise dosing, relatively fast onset compared to traditional oral edibles, and a clean, functional delivery method. Consumers new to cannabis or to precise micro-dosing may find this format more approachable than higher-dose confections. As with any edible, starting with a single unit and allowing adequate time before re-dosing is advisable.
LEVEL occupies a premium tier in the cannabis market, though its claim to that positioning is rooted in scientific rigor and formulation precision rather than in ornate packaging or celebrity association. The brand invests in cannabinoid research and dose accuracy, which commands a premium price point. For consumers who define luxury as quality of outcome and intellectual credibility rather than decorative presentation, LEVEL fits that description.
LEVEL is led by Chris Emerson, PhD, who is publicly identified as both CEO and chief scientist. Broader corporate ownership structure, including any investment rounds or parent company relationships, has not been extensively detailed in major trade press sources reviewed for this profile. The founders have not made all corporate registration details publicly prominent, and consumers seeking precise ownership disclosure should consult California and New York regulatory filings.
Yes — one of LEVEL's most documented differentiators is its use of minor cannabinoids including CBN, THCV, and CBC in its formulations, alongside more common THC and CBD. The brand's research-oriented team has positioned these cannabinoid combinations as tools for specific functional outcomes, such as rest support or energy modulation. Product availability in New York may vary; current menus at licensed dispensaries reflect the most up-to-date inventory.
Kiva Confections
Kiva shares LEVEL's California origins and commitment to precise, consistent dosing in the edibles category, making it a natural companion for consumers drawn to formulation rigor.
Wana Brands
Wana's emphasis on fast-acting and targeted cannabinoid formulations in gummy formats appeals to the same consumer who values predictable onset and effect clarity that LEVEL prioritizes.
Kikoko
Kikoko's wellness-forward, low-dose approach to cannabis edibles resonates with the same analytically minded, routine-oriented consumer that LEVEL attracts.
Cann
Cann's micro-dose social tonics share LEVEL's philosophy of precise, low-threshold consumption, appealing to consumers who want to integrate cannabis into daily life without intensity.
1906
1906's fast-acting, effect-targeted pills occupy a closely adjacent product space to LEVEL's Tablinguals, drawing consumers who value speed of onset and functional cannabinoid blending.
Pick your store
We'll show pricing, deals, and delivery zones for the store you pick. You can switch any time from the header.